Laval, Que.-based Bausch Health Companies’ eye-health spin-out listed shares on the New York and Toronto Stock Exchanges at US$18 each, raising US$630 million if the over-allotment option is not exercised. (The Logic)
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
How machine learning is transforming biotech research
Crush of cargo containers sends West Coast ports to bottom of global rankings
China’s Tencent pulled out of financing ‘Top Gun: Maverick’ over pro-U.S. messaging
CPP Investments launches growth equity group
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.